Induction R-CHOP therapy facilitates curative resection of initially unresectable hyaline-vascular unicentric Castleman disease: a case report

Read full text Summarise with VIRAT
Authors: Jianyong Ding
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This is the first comprehensive report demonstrating that short-course R-CHOP chemoimmunotherapy safely and effectively serves as a "bridge-to-surgery" for initially unresectable hyaline-vascular unicentric Castleman disease (HV-UCD). The 8.3×5.5 cm mediastinal tumor, characterized by CD20+ B-cell hyperplasia and increased vascularity, encases the right pulmonary artery and bronchus with high risks of catastrophic hemorrhage and airway injury. Four 21-day R-CHOP cycles achieved >50% tumor shrinkage, established a clear tissue plane, facilitated safe R0 resection, and yielded 12-month disease-free survival without severe adverse events, offering novel evidence for high-risk HV-UCD management.

Fields of Study & Subjects

Lymphadenopathy Diagnosis and Analysis Viral-associated cancers and disorders Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Figshare
Publication date
21 March 2026
Language
EN
Document type
Dataset